Lone Mouritsen1, Manuela Kronschnabl, Gunnar Lose. 1. Department of Gynecology and Obstetrics, Herlev Hospital, University of Copenhagen, 2730 Herlev, Copenhagen, Denmark. lonemouritsen@newmail.dk
Abstract
INTRODUCTION AND HYPOTHESIS: The aim of this paper is to study if xenograft reinforcement of vaginal repair reduces recurrence of prolapse. METHODS: Results 1-5 years after vaginal repair were studied in 41 cases with xenograft and in 82 matched controls without. Symptoms were evaluated by a validated questionnaire and anatomy by pelvic organ prolapse quantification (POPQ). RESULTS: Significant more cases, 97% versus 81% controls, felt cured or much improved (p = 0.02); 11% of cases and 19% of controls had POP symptoms, POPQ > -1 was found in 31% cases and 24% controls. Defining recurrence as POPQ > -1 plus symptoms revealed recurrence in 3% of cases and 12% controls. None of the recurrence rates was significantly different for cases versus controls. No vaginal erosions were seen. Previous surgery was a significant risk factor with odds ratio 7.3 for another recurrence. CONCLUSIONS: Recurrence rates defined by POPQ plus symptoms were low compared to literature. Xenograft reinforcement might improve results.
INTRODUCTION AND HYPOTHESIS: The aim of this paper is to study if xenograft reinforcement of vaginal repair reduces recurrence of prolapse. METHODS: Results 1-5 years after vaginal repair were studied in 41 cases with xenograft and in 82 matched controls without. Symptoms were evaluated by a validated questionnaire and anatomy by pelvic organ prolapse quantification (POPQ). RESULTS: Significant more cases, 97% versus 81% controls, felt cured or much improved (p = 0.02); 11% of cases and 19% of controls had POP symptoms, POPQ > -1 was found in 31% cases and 24% controls. Defining recurrence as POPQ > -1 plus symptoms revealed recurrence in 3% of cases and 12% controls. None of the recurrence rates was significantly different for cases versus controls. No vaginal erosions were seen. Previous surgery was a significant risk factor with odds ratio 7.3 for another recurrence. CONCLUSIONS: Recurrence rates defined by POPQ plus symptoms were low compared to literature. Xenograft reinforcement might improve results.
Authors: Thomas L Wheeler; Holly E Richter; Angela G Duke; Kathryn L Burgio; David T Redden; R Edward Varner Journal: Am J Obstet Gynecol Date: 2006-05 Impact factor: 8.661